Combined +58 and +55 BCL11A enhancer Editing Yields Exceptional Efficiency, Specificity and HbF Induction in Human and NHP Preclinical Models

MLA

Myriam Armant, et al. “Combined +58 and +55 BCL11A Enhancer Editing Yields Exceptional Efficiency, Specificity and HbF Induction in Human and NHP Preclinical Models.” Blood, vol. 138, Nov. 2021, p. 1852. EBSCOhost, https://doi.org/10.1182/blood-2021-152634.

APA

Myriam Armant, Selami Demirci, David R. Williams, Amornrat Tangprasittipap, Stacy Maitland, Pengpeng Liu, Daniel E. Bauer, J. Keith Joung, Karl Petri, Danilo Pellin, Jing Zeng, John F. Tisdale, Linda Yingqi Lin, John P. Manis, Kevin Luk, Daniela Abriss, Scot A. Wolfe, Yuxuan Wu, Christian Brendel, … Esther Mintzer. (2021). Combined +58 and +55 BCL11A enhancer Editing Yields Exceptional Efficiency, Specificity and HbF Induction in Human and NHP Preclinical Models. Blood, 138, 1852. https://doi.org/10.1182/blood-2021-152634

Chicago

Myriam Armant, Selami Demirci, David R. Williams, Amornrat Tangprasittipap, Stacy Maitland, Pengpeng Liu, Daniel E. Bauer, et al. 2021. “Combined +58 and +55 BCL11A Enhancer Editing Yields Exceptional Efficiency, Specificity and HbF Induction in Human and NHP Preclinical Models.” Blood 138 (November): 1852. doi:10.1182/blood-2021-152634.